About US
Contact us
-
World Health Assembly begins in GenevaAs the 64th World Health Assembly gets underway in Geneva, the body will consider "an array of subjects pertaining to reforms of the organisation and its financing, vaccines, fake medicines, and influ2011/5/18
-
Nordic Naturals' dietary supplements earn NSF certificationNordic Naturals® has earned certification from NSF International, verifying that its new LEED-designed corporate headquarters complies with Good Manufacturing Practices (GMP) as set forth in NSF/A2011/5/18
-
Pfizer seeks U.S. FDA, Japanese MHLW approval for crizotinib NDA to treat ALK-positive advanced NSCLCPfizer Inc. announced today that its New Drug Application (NDA) for crizotinib, an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor, has been accepted for filing and granted Priority Rev2011/5/18
-
FDA nod for hepatitis C drugBy Dr Ananya Mandal, MD Merck & Co have finally won the Food and Drugs Administration – FDA’S approval on Friday to sell a new drug considered a major advance against the liver-destroying hepat2011/5/17
-
FDA warns consumers about look like antimicrobial dietary supplementsThe following was released yesterday by the FDA: Fast Facts The FDA is warning consumers not to use products marketed as dietary supplements that also claim to be antimicrobial (antibiotic, anti2011/5/17
-
Vitamin D may improve exercise capacity, respiratory muscle strength in COPD patientsVitamin D supplements may help patients with chronic obstructive pulmonary disease (COPD) get more from their pulmonary rehabilitation programs, according to a study conducted by researchers from Belg2011/5/16
-
Merck receives FDA approval for Victrelis to treat chronic hepatitis CThe U.S. Food and Drug Administration today approved Victrelis (boceprevir) to treat certain adults with chronic hepatitis C. Victrelis is used for patients who still have some liver function, and who2011/5/16
-
Linguamatics introduces I2E award-winning software for pharmaceutical companiesLinguamatics, the leader in NLP-based enterprise text mining for life sciences and other markets, announces the latest release of its award-winning software platform, I2E. Version 3.2 reflects Linguam2011/5/13
-
Health Canada approves EMEND IV formulation to prevent chemotherapy-induced nausea, vomitingToday Merck announced that Health Canada has approved the new intravenous formulation of EMEND® IV (fosaprepitant dimeglumine). Used in combination with a 5-HT3 antagonist class of antiemetics and2011/5/13
-
FDA Fast Tracks Bayer's Cancer DrugThe US Food and Drug Administration has granted fast-track designation for Bayer Healthcare's regorafenib for the treatment of gastrointestinal stromal tumours. The fast-track process is designed t2011/5/12